Compare TRNS & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRNS | OFIX |
|---|---|---|
| Founded | 1964 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.9M | 500.2M |
| IPO Year | 1995 | 1998 |
| Metric | TRNS | OFIX |
|---|---|---|
| Price | $74.54 | $12.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $116.00 | $17.25 |
| AVG Volume (30 Days) | 121.6K | ★ 285.6K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ 0.37 | N/A |
| Revenue | $278,421,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $21.75 | $6.32 |
| Revenue Next Year | $7.55 | $6.01 |
| P/E Ratio | $202.16 | ★ N/A |
| Revenue Growth | ★ 7.30 | 2.85 |
| 52 Week Low | $50.23 | $10.25 |
| 52 Week High | $97.08 | $17.00 |
| Indicator | TRNS | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 33.61 |
| Support Level | $70.35 | $10.55 |
| Resistance Level | $81.17 | $16.38 |
| Average True Range (ATR) | 3.30 | 0.49 |
| MACD | -1.00 | -0.09 |
| Stochastic Oscillator | 31.29 | 11.81 |
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.